Form 4 for EW Edwards Lifesciences
Accepted 2023-05-15 00:00:00 ET · period of report 2023-05-11 · accession 0001225208-23-005915 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-05-15 | 2023-05-11 | EW | Szyman Catherine M. | CVP, Critical Care | A - Grant | $0.00 | +6,525 | 35.1K | +23% | $0 |
| DM | 2023-05-15 | 2023-05-11 | EW | Szyman Catherine M. | CVP, Critical Care | A - Grant | $0.00 | +58.6K | 8,175 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-11 | A | A | 6,525 | $0.00 | 35,055.78 | D | — | — | (F1) These restricted stock units were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |
| 2 | Derivative | Employee Stock Option (Right to Acquire) | 2023-05-11 | A | A | 50,400 | $0.00 | 50,400 | D | $88.78 · 2024-05-11 to 2023-05-10 | 50,400 Common Stock | (F2) These options were granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments. |
| 3 | Derivative | Performance Rights | 2023-05-11 | A | A | 8,175 | $0.00 | 8,175 | D | — · 2026-05-11 to — | 8,175 Common Stock | (F3) Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 11, 2023 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and scheduled to vest on May 11, 2026. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 175% of the Target Awards. |